Trump is trying to argue that the US is doing better than Europe

0
60


A nurse prepares a shot during a study of a possible COVID-19 vaccine developed by the National Institutes of Health and Moderna Inc. on Monday, July 27, 2020, in Binghamton, NY Hans Pennink / AP

Trump administration reached $ 1.525 billion deal with Moderna Inc. to manufacture and deliver 100 million doses of the company’s Covid-19 vaccine once approved, according to a press release from the US Department of Health and Human Services.

President Trump announced the deal during a press briefing on Tuesday.

Moderna is one of several companies making the ‘risky’ vaccine, as the industry calls it, which means the company is currently making the vaccine before it is approved. Clinical trials are currently underway to test whether it is safe and effective.

Under this contract, worth up to $ 1.525 billion for 100 million doses, the doses would be owned by the U.S. government and would be distributed and used as part of its Covid-19 vaccination campaign. If the doses are used, they would be provided to Americans at no cost. The government can also acquire up to 400 million additional doses of this vaccine.

The vaccine, called mRNA-1273, was developed by Moderna in collaboration with the US government. It received development assistance from the National Institute of Allergy and Infectious Diseases, and the US Biomedical Advance Research and Development Authority, known as BARDA, supported advanced clinical trials. and helped expand manufacturing. Moderna’s advanced stage clinical trial, which began July 27, is the first government-funded Phase 3 clinical trial for a Covid-19 vaccine in the United States.

This contract is part of the US government’s Operation Warp Speed, the federal campaign to bring vaccines and therapeutics to market as quickly and safely as possible. HHS said the goal is to provide effective vaccines to the American people by the end of the year.

The government also struck a deal with Pfizer in July to produce 100 million doses of its vaccine. In August, it struck a similar 100 million-dose deal with Janssen, the vaccine arm of Johnson & Johnson, for its vaccine candidate. It has other agreements with GlaxoSmithKline, Sanofi Pasteur, Novavax and AstraZeneca.

There are 28 Covid-19 vaccines in human trials, according to the World Health Organization.

“By creating a vaccine portfolio for Operation Warp Speed, the Trump administration is increasing the likelihood that the United States will have at least one safe and effective vaccine by 2021,” HHS Secretary Alex said. Azar, in Tuesday’s press release. “Today’s investment represents the next step in supporting this vaccine candidate from early development by Moderna and the National Institutes of Health, through clinical trials and now large-scale manufacturing, with the potential to bring hundreds of millions of safe and effective products. doses to the American people.

LEAVE A REPLY

Please enter your comment!
Please enter your name here